Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Tonix Pharmaceuticals has expanded its ongoing partnership with non-profit Southern Research to study T-cell immune responses to SARS-CoV-2, the novel coronavirus that causes Covid-19.
The partners formed an alliance in March this year to develop a vaccine against Covid-19 using Tonix’s horsepox vaccine platform.
They agreed to develop and conduct animal testing of TNX-1800, a live modified horsepox virus vaccine formulated for percutaneous administration.
As part of the expanded collaboration, the partners aim to generate a blueprint of the human immune system’s response to Covid-19 by analysing samples from who have recovered.